Home

chlapec jed Derbevilleův test kras marker Zůstává kus dopad

The current understanding on the impact of KRAS on colorectal cancer -  ScienceDirect
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect

A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... |  Download Scientific Diagram
A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... | Download Scientific Diagram

Computational Analysis of KRAS Mutations: Implications for Different  Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations | PLOS ONE

Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The  Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies

Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers

Integrated multi-omics characterization of KRAS mutant colorectal cancer
Integrated multi-omics characterization of KRAS mutant colorectal cancer

Hitting an Elusive Target in Pancreatic Cancer - NCI
Hitting an Elusive Target in Pancreatic Cancer - NCI

KRAS-mutant non-small cell lung cancer: Converging small molecules and  immune checkpoint inhibition - eBioMedicine
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine

The improbable targeted therapy: KRAS as an emerging target in non-small  cell lung cancer (NSCLC) - ScienceDirect
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect

KRAS Screening & Profiling
KRAS Screening & Profiling

Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated  Non-Small-Cell Lung Cancer
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer

Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer  treatment - ScienceDirect
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect

The Trouble With KRAS - Cancer Commons
The Trouble With KRAS - Cancer Commons

KRAS mutations predict response to EGFR inhibitors - ScienceDirect
KRAS mutations predict response to EGFR inhibitors - ScienceDirect

Targeting KRAS mutant cancers: from druggable therapy to drug resistance |  Molecular Cancer | Full Text
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text

Chemically modified MIR143-3p exhibited anti-cancer effects by impairing  the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic  Acids
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids

KRAS mutation A treatment target
KRAS mutation A treatment target

Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future  Perspectives
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives

Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel  Insights Into Therapeutic Strategies
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and  Immunologic Pathways, Therapeutic Advantages and Restrictions
Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions

Immune modulatory effects of oncogenic KRAS in cancer | Nature  Communications
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications

An integrative pharmacogenomics analysis identifies therapeutic targets in  KRAS-mutant lung cancer - eBioMedicine
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer - eBioMedicine

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct  Activating KRAS Mutations | Journal of Proteome Research
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research

IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past  Efforts to Future Challenges
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges

KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy |  SpringerLink
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | SpringerLink